43 ORAL The Swiss experience with isolated limb perfusion with high-doses tumor necrosis factor-alpha and melphalan, a limb salvage strategy for non-resectable soft tissue sarcomas of the extremities

S. Cherix1, M. Speiser2, M. Matter3, L. Guillou4, D. Lienard5, F. Lejeune5, R. Mirimanoff6, S. Leyvraz5, P. Leyvraz1. 1University Hospital, Orthopaedics and Traumatology, Lausanne, Switzerland; 2Universty of Lausanne, Medecine, Lausanne, Switzerland; 3University Hospital, General Surgery, Lausanne, Switzerland; 4University Hospital, Pathology, Lausanne, Switzerland; 5University Hospital, Medical Oncology, Lausanne, Switzerland; 6University Hospital, Radiation Oncology, Lausanne, Switzerland